PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,549 | -23.2% | 408,989 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $16,332 | -1.5% | 407,542 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $16,581 | +6.3% | 406,286 | +0.5% | 0.00% | -33.3% |
| Q4 2022 | $15,603 | -99.9% | 404,122 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $20,908,000 | -7.7% | 393,074 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $22,661,000 | -21.4% | 388,690 | +2.9% | 0.00% | 0.0% |
| Q1 2022 | $28,831,000 | +27.6% | 377,765 | +0.6% | 0.00% | +50.0% |
| Q4 2021 | $22,591,000 | +8.6% | 375,461 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $20,809,000 | -8.2% | 371,588 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $22,673,000 | -11.1% | 373,652 | +2.7% | 0.00% | -33.3% |
| Q1 2021 | $25,510,000 | +15.4% | 363,963 | -1.4% | 0.00% | +50.0% |
| Q4 2020 | $22,098,000 | -1.3% | 369,289 | -0.8% | 0.00% | -33.3% |
| Q3 2020 | $22,378,000 | +14.7% | 372,221 | +0.1% | 0.00% | +50.0% |
| Q2 2020 | $19,503,000 | +39.5% | 371,707 | -10.9% | 0.00% | 0.0% |
| Q1 2020 | $13,984,000 | -26.3% | 417,069 | -0.5% | 0.00% | 0.0% |
| Q4 2019 | $18,986,000 | +21.8% | 419,121 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $15,583,000 | -11.4% | 409,320 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $17,586,000 | +25.9% | 404,373 | +10.2% | 0.00% | 0.0% |
| Q1 2019 | $13,965,000 | -70.1% | 366,930 | -66.2% | 0.00% | -75.0% |
| Q4 2018 | $46,634,000 | -26.1% | 1,084,012 | -15.6% | 0.01% | -11.1% |
| Q3 2018 | $63,146,000 | +18.4% | 1,284,763 | -22.8% | 0.01% | +12.5% |
| Q2 2018 | $53,349,000 | -5.2% | 1,664,554 | -7.8% | 0.01% | -11.1% |
| Q1 2018 | $56,265,000 | -32.2% | 1,806,268 | -0.6% | 0.01% | -30.8% |
| Q4 2017 | $82,949,000 | +23.4% | 1,817,066 | +1.5% | 0.01% | +18.2% |
| Q3 2017 | $67,216,000 | -31.5% | 1,790,052 | -13.0% | 0.01% | -38.9% |
| Q2 2017 | $98,109,000 | -11.8% | 2,056,792 | -15.7% | 0.02% | -14.3% |
| Q1 2017 | $111,277,000 | +33.6% | 2,440,280 | -5.4% | 0.02% | +23.5% |
| Q4 2016 | $83,318,000 | -27.9% | 2,579,501 | -23.6% | 0.02% | -26.1% |
| Q3 2016 | $115,581,000 | -22.7% | 3,377,591 | -23.8% | 0.02% | -28.1% |
| Q2 2016 | $149,483,000 | -31.7% | 4,431,743 | +7.2% | 0.03% | -31.9% |
| Q1 2016 | $218,986,000 | -29.5% | 4,133,374 | +2.2% | 0.05% | -27.7% |
| Q4 2015 | $310,485,000 | +92.9% | 4,043,295 | +3.2% | 0.06% | +80.6% |
| Q3 2015 | $160,963,000 | -41.1% | 3,916,370 | +1.3% | 0.04% | -35.7% |
| Q2 2015 | $273,391,000 | -28.7% | 3,865,827 | -10.4% | 0.06% | -29.1% |
| Q1 2015 | $383,496,000 | -1.2% | 4,316,221 | -1.4% | 0.08% | -3.7% |
| Q4 2014 | $388,123,000 | -21.9% | 4,377,651 | -14.7% | 0.08% | -24.8% |
| Q3 2014 | $497,225,000 | +14.5% | 5,130,265 | +8.5% | 0.11% | +16.0% |
| Q2 2014 | $434,197,000 | +33.5% | 4,726,726 | +1.7% | 0.09% | +28.8% |
| Q1 2014 | $325,250,000 | -40.7% | 4,647,096 | -51.3% | 0.07% | +15.9% |
| Q4 2013 | $548,026,000 | +132.7% | 9,532,534 | +94.7% | 0.06% | +6.8% |
| Q3 2013 | $235,489,000 | -31.9% | 4,896,830 | -59.0% | 0.06% | +28.3% |
| Q2 2013 | $345,952,000 | – | 11,929,406 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |